Clinical

Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR'd Kidneys & More

10 days ago   |   By Xconomy

During the state of the union address this year, President Trump pledged to end HIV transmission within the next decade. A key part of that plan is an HIV prevention drug made by Gilead Sciences. That drug has now become the center of a patent dispute between the Foster City, CA, drug maker and the federal government. This week, the government filed a patent infringement suit in federal court against Gilead. Though Gilead had initially won approval for its drug, Truvada, as a post-infection treatment, its approval for HIV prevention followed research and clinical testing by the Centers...
Read more ...

 


Search by Tags

   Clinical      Research      Drug      Drugs      Science      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      A2 Therapeutics      Abraham Scaria      Acadia Pharmaceuticals      ADHD      Aerie Pharmaceuticals      Alzheimer's disease      Anaptys Bio      Antibiotic      Arkuda Therapeutics      Ashley Winslow      AstraZeneca      Atopic dermatitis      Biogen      Biotech      Biouniversa      Centers for Disease Control and Prevention      Checkmate Pharmaceuticals      China      Clinical trials      CRISPR      Dauntless Pharmaceuticals      David Altarac      David Hollander      Deals      Dementia      Drug Delivery      EGenesis      EIP Pharma      Eli Kalif      Entasis therapeutics      Eosinophilic asthma      Epizyme      Etokimab      FDA      Foundation Medicine      Galera Therapeutics      Gene editing      Gilead Sciences      Halozyme Therapeutics      HIV      Infection      Inflammation      Intrepida Bio      Investing      IVERIC bio      Kleem Chaudhary      Life Sciences      MD Anderson Cancer Center in Houston      Medical Device      Neflamapimod      Odylia Therapeutics      Pancreatic Cancer      Pharmakon Advisors      Ponni Subbiah      President Trump      RedHill BioPharma      Regenerative Medicine      RNA editing      Robin Isaacs      RoboticsAI      Royalty Pharma      Samsung Bioepis      Sangamo Therapeutics      Section 32      Shape Therapeutics      Shire      Stada Arzneimittel      Startups      Stephen Hahn      Steve Kafka      Stryker      Sung Lee      SuperNus Pharmaceuticals      Takeda Pharmaceutical      Teva Pharmaceutical      Third Rock Ventures      University of Pennsylvania      University of Texas MD Anderson Cancer Center      Vertex Pharmaceuticals  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Cover Image, Volume 87, Issue 12

Cover Image, Volume 87, Issue 12

Reverse Cover: The cover image is based on the Review Critical assessment of methods of protein structure prediction ‐Round XIII by Andriy Kryshtafovych, Torsten Schwede, Maya... Read more ...

Patient Storytelling: There's an Art to it!

Patient Storytelling: There's an Art to it!

After 30-plus years working in Washington DC, it's clear healthcare decision makers recognize that a patient's story can add value to a discussion when data cannot. While the... Read more ...

Tracking inheritance of human mitochondrial DNA

New insight into how genetic information stored in human mitochondria is passed from one generation to the next could have important implications for genetic counseling of... Read more ...

Researchers clear the path for 'designer' plants

A team of researchers at the University of Georgia has found a way to identify gene regulatory elements that could help produce "designer" plants and lead to improvements in... Read more ...

New method takes analysis of genetic libraries to next level

Uppsala researchers have developed a new method for investigating dynamic processes in large genetic libraries. By using this method to study cell cycle regulation,researchers... Read more ...

Fate Therapeutics: Manager, Quality Assurance

Fate Therapeutics: Fate Therapeutics seeks an experienced, motivated Manager of Quality Assurance to support Fate's internal and external cGMP manufacturing operations. 92121... Read more ...

Discovery of disease- and drug-specific pathways through community...

AbstractMotivationIn light of the massive growth of the scientific literature, text mining is increasingly used to extract biological pathways. Though multiple tools explore... Read more ...

SPDI: Data Model for Variants and Applications at NCBI

AbstractMotivationNormalizing sequence variants on a reference, projecting them across congruent sequences, and aggregating their diverse representations are critical to the... Read more ...

DeepMSA: constructing deep multiple sequence alignment to improve contact...

AbstractMotivationThe success of genome sequencing techniques has resulted in rapid explosion of protein sequences. Collections of multiple homologous sequences can provide... Read more ...

SBML2Modelica: Integrating biochemical models within open-standard...

AbstractMotivationSBML is the most widespread language for the definition of biochemical models. Although dozens of SBML simulators are available, there is a general lack of... Read more ...